Fexofenadine Hydrochloride And Pseudoephedrine Hydrochloride 51316-0015
Product NDC
51316-0015- Manufacturer
- Cvs Health Corp
- Dosage Form
- Tablet, Extended Release
- Route
- Oral
- Product Type
- Human Otc Drug
- Marketing Start
- June 3, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA215434
Active Ingredients
| Ingredient | Strength |
|---|---|
| Fexofenadine Hydrochloride | 60 mg/1 |
| Pseudoephedrine Hydrochloride | 120 mg/1 |
Drug Class
Adrenergic alpha-Agonists [MoA]Histamine H1 Receptor Antagonists [MoA]Histamine-1 Receptor Antagonist [EPC]
Packaging Options(2)
4 BLISTER PACK in 1 CARTON (51316-015-20) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
6 BLISTER PACK in 1 CARTON (51316-015-30) / 5 TABLET, EXTENDED RELEASE in 1 BLISTER PACK
External Resources